196 related articles for article (PubMed ID: 35846988)
1. The Anti-Histamine Azelastine, Identified by Computational Drug Repurposing, Inhibits Infection by Major Variants of SARS-CoV-2 in Cell Cultures and Reconstituted Human Nasal Tissue.
Konrat R; Papp H; Kimpel J; Rössler A; Szijártó V; Nagy G; Madai M; Zeghbib S; Kuczmog A; Lanszki Z; Gesell T; Helyes Z; Kemenesi G; Jakab F; Nagy E
Front Pharmacol; 2022; 13():861295. PubMed ID: 35846988
[No Abstract] [Full Text] [Related]
2. Antiviral Potential of Azelastine against Major Respiratory Viruses.
Fischhuber K; Bánki Z; Kimpel J; Kragl N; Rössler A; Bolze A; Muellauer B; Angerer J; Nagy G; Nagy E; Szijarto V
Viruses; 2023 Nov; 15(12):. PubMed ID: 38140540
[TBL] [Abstract][Full Text] [Related]
3. Double-blind trials of azelastine nasal spray monotherapy versus combination therapy with loratadine tablets and beclomethasone nasal spray in patients with seasonal allergic rhinitis. Rhinitis Study Groups.
Berger WE; Fineman SM; Lieberman P; Miles RM
Ann Allergy Asthma Immunol; 1999 Jun; 82(6):535-41. PubMed ID: 10400480
[TBL] [Abstract][Full Text] [Related]
4. Double-blind, placebo-controlled trial of reformulated azelastine nasal spray in patients with seasonal allergic rhinitis.
Bernstein JA; Prenner B; Ferguson BJ; Portnoy J; Wheeler WJ; Sacks HJ
Am J Rhinol Allergy; 2009; 23(5):512-7. PubMed ID: 19807985
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of twice daily azelastine nasal spray in patients with seasonal allergic rhinitis.
Horak F
Ther Clin Risk Manag; 2008 Oct; 4(5):1009-22. PubMed ID: 19209282
[TBL] [Abstract][Full Text] [Related]
6. Azelastine nasal spray: a review of pharmacology and clinical efficacy in allergic and nonallergic rhinitis.
Lieberman PL; Settipane RA
Allergy Asthma Proc; 2003; 24(2):95-105. PubMed ID: 12776442
[TBL] [Abstract][Full Text] [Related]
7. Open-label evaluation of azelastine nasal spray in patients with seasonal allergic rhinitis and nonallergic vasomotor rhinitis.
Lieberman P; Kaliner MA; Wheeler WJ
Curr Med Res Opin; 2005 Apr; 21(4):611-8. PubMed ID: 15899111
[TBL] [Abstract][Full Text] [Related]
8. Early intervention with azelastine nasal spray may reduce viral load in SARS-CoV-2 infected patients.
Klussmann JP; Grosheva M; Meiser P; Lehmann C; Nagy E; Szijártó V; Nagy G; Konrat R; Flegel M; Holzer F; Groß D; Steinmetz C; Scherer B; Gruell H; Schlotz M; Klein F; de Aragão PA; Morr H; Al Saleh H; Bilstein A; Russo B; Müller-Scholtz S; Acikel C; Sahin H; Werkhäuser N; Allekotte S; Mösges R
Sci Rep; 2023 Apr; 13(1):6839. PubMed ID: 37100830
[TBL] [Abstract][Full Text] [Related]
9. Antiviral Activity of Repurposing Ivermectin against a Panel of 30 Clinical SARS-CoV-2 Strains Belonging to 14 Variants.
Delandre O; Gendrot M; Jardot P; Le Bideau M; Boxberger M; Boschi C; Fonta I; Mosnier J; Hutter S; Levasseur A; La Scola B; Pradines B
Pharmaceuticals (Basel); 2022 Apr; 15(4):. PubMed ID: 35455442
[TBL] [Abstract][Full Text] [Related]
10. Azelastine hydrochloride: a review of pharmacology, pharmacokinetics, clinical efficacy and tolerability.
Bernstein JA
Curr Med Res Opin; 2007 Oct; 23(10):2441-52. PubMed ID: 17723160
[TBL] [Abstract][Full Text] [Related]
11. Cysteamine exerts in vitro antiviral activity against the SARS-CoV-2 Delta and Omicron variants.
Alonzi T; Aiello A; Repele F; Falasca L; Francalancia M; Garbuglia AR; Delogu G; Nicastri E; Piacentini M; Goletti D
Cell Death Discov; 2022 Jun; 8(1):288. PubMed ID: 35705564
[TBL] [Abstract][Full Text] [Related]
12. Histamine skin test reactivity following single and multiple doses of azelastine nasal spray in patients with seasonal allergic rhinitis.
Pearlman DS; Grossman J; Meltzer EO
Ann Allergy Asthma Immunol; 2003 Sep; 91(3):258-62. PubMed ID: 14533657
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of azelastine 0.15% nasal spray administered once daily in subjects with seasonal allergic rhinitis.
van Bavel J; Howland WC; Amar NJ; Wheeler W; Sacks H
Allergy Asthma Proc; 2009; 30(5):512-8. PubMed ID: 19747429
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of azelastine nasal spray in patients with an unsatisfactory response to loratadine.
Berger WE; White MV;
Ann Allergy Asthma Immunol; 2003 Aug; 91(2):205-11. PubMed ID: 12952117
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of azelastine 0.15% nasal spray and azelastine 0.10% nasal spray in patients with seasonal allergic rhinitis.
Shah S; Berger W; Lumry W; La Force C; Wheeler W; Sacks H
Allergy Asthma Proc; 2009; 30(6):628-33. PubMed ID: 19930788
[TBL] [Abstract][Full Text] [Related]
16. Pharmacometric Modeling of the Impact of Azelastine Nasal Spray on SARS-CoV-2 Viral Load and Related Symptoms in COVID-19 Patients.
Dings C; Meiser P; Holzer F; Flegel M; Selzer D; Nagy E; Mösges R; Klussmann JP; Lehr T
Pharmaceutics; 2022 Sep; 14(10):. PubMed ID: 36297492
[TBL] [Abstract][Full Text] [Related]
17. Azelastine nasal spray inhibiting sympathetic function on human nasal mucosa in patients with allergy rhinitis.
Cheng LH; Lee JC; Wu PC; Lin YY; Chu YH; Wang HW
Rhinology; 2019 Aug; 57(4):268-272. PubMed ID: 30887967
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of azelastine nasal spray in the treatment of vasomotor (perennial nonallergic) rhinitis.
Banov CH; Lieberman P;
Ann Allergy Asthma Immunol; 2001 Jan; 86(1):28-35. PubMed ID: 11206234
[TBL] [Abstract][Full Text] [Related]
19. Recognition of Variants of Concern by Antibodies and T Cells Induced by a SARS-CoV-2 Inactivated Vaccine.
Melo-González F; Soto JA; González LA; Fernández J; Duarte LF; Schultz BM; Gálvez NMS; Pacheco GA; Ríos M; Vázquez Y; Rivera-Pérez D; Moreno-Tapia D; Iturriaga C; Vallejos OP; Berríos-Rojas RV; Hoppe-Elsholz G; Urzúa M; Bruneau N; Fasce RA; Mora J; Grifoni A; Sette A; Weiskopf D; Zeng G; Meng W; González-Aramundiz JV; González PA; Abarca K; Ramírez E; Kalergis AM; Bueno SM
Front Immunol; 2021; 12():747830. PubMed ID: 34858404
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of azelastine nasal spray in seasonal allergic rhinitis patients who remain symptomatic after treatment with fexofenadine.
LaForce CF; Corren J; Wheeler WJ; Berger WE;
Ann Allergy Asthma Immunol; 2004 Aug; 93(2):154-9. PubMed ID: 15328675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
